• June 29, 2021  

    Helping Patients Access Investigational Treatments

    With: Lea Ann Browning-McNeeSusan C. Winckler, RPh, Esq.

    For some advanced cancer patients, the best course of action may lie beyond standard treatment options. Some of these patients can enroll in clinical trials that investigate promising new treatments. But others may find their best option is to apply for individual “expanded access” to an investigational treatment. Here, our Curious Dr. George asks two leaders from the Reagan-Udall Foundation for the Food and… Read more »

  • June 12, 2021  

    Navigating Pancreatic Cancer: Apps at Your Fingertips Bookmark

    Lola Rahib, PhD

    Article from Let’s Win! Pancreatic Cancer: Learn how patients and caregivers can utilize cancer apps to find resources, track symptoms, contribute to research, and more.

    .

  • June 12, 2021  

    Drafting Your Health Care Team Bookmark

    Lola Rahib, PhD

    Article from Let’s Win! Pancreatic Cancer: Patients need different types of healthcare professionals when diagnosed with pancreatic cancer. A multidisciplinary team of experts are care professionals that work together and have different roles in helping patients with pancreatic cancer.

    .

  • February 20, 2021  

    Patient education: Pancreatic cancer (Beyond the Basics) Bookmark

    George Lundberg, MD

    UpToDate provides an authoritative overview of pancreatic cancer diagnosis and treatment.

    .

  • January 26, 2021  

    Behind the Scenes at Cancer Commons: Working with Patients

    With: Emma Shtivelman, PhD

    Cancer Commons helps advanced cancer patients identify and access their best-possible treatments. Here, our Curious Dr. George asks Chief Scientist Emma Shtivelman, PhD, for an inside look at how she helps the people who turn to us for guidance. Curious Dr. George: As Chief Scientist at Cancer Commons for many years, you have helped thousands of patients with advanced cancer to better understand their… Read more »

  • December 4, 2020  

    What Is a Cancer Commons Options Report?

    With: Lola Rahib, PhD

    As a Cancer Commons Scientist, Lola Rahib, PhD, helps cancer patients and caregivers navigate treatment. Some of these patients receive a Cancer Commons Options Report. Here, our Curious Dr. George asks Dr. Rahib to share what goes into each Options Report. Curious Dr. George: Cancer Commons provides advanced cancer patients who seek information with additional options for them to consider, all free of charge. What does… Read more »

  • November 23, 2020  

    Hydrogen Peroxide Appears to Treat Pre-Cancerous Oral Lesion in “N-of-One” Experiment

    With: Ronald Piana

    Numerous patients come to Cancer Commons because they wonder if their best cancer treatment option may lie beyond standard care. For many patients, this will mean receiving treatment through a clinical trial. However, with the input and supervision of their medical care team, a select number of patients may arrange to try a non-standard treatment outside of a normal clinical trial. This approach is… Read more »

  • October 10, 2020  

    NCCN Guidelines for Patients: Acute Myeloid Leukemia Bookmark

    George Lundberg, MD

    PDF from the National Comprehensive Cancer Network curated by Contributing Editor George Lundberg, MD, who notes: 

    The National Comprehensive Cancer Network (NCCN) has issued a 2020 edition of its Guidelines for Patients about acute myeloid leukemia.

    Go to full document published by the NCCN.

    .

  • October 8, 2020  

    Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer Bookmark

    George Lundberg, MD

    Research paper from JAMA Oncology curated by Contributing Editor George Lundberg, MD, who notes: 

    This study linked coffee consumption with longer survival and lower death rates in advanced colorectal cancer.

    .

  • October 8, 2020  

    Pediatric Cancer: The “Day One Talk” Bookmark

    Marty Tenenbaum, PhD

    Article from the Journal of Clinical Oncology, curated by Cancer Commons founder Marty Tenenbaum, PhD.

    This piece discusses a “method of delivering bad news to parents of children with cancer in hopes that our approach may be helpful to others and may spur discussion.”

    .